OUTFRONT Media Inc. Common Stock vs Pfizer Inc — how do they compare? OUTFRONT Media Inc. Common Stock trades at $29.55 (market cap $5.33B), while Pfizer Inc trades at $29.52 (market cap $161.70B). The key difference: Pfizer Inc is far larger — about 30.3× OUTFRONT Media Inc. Common Stock's market cap, and Pfizer Inc pays the higher dividend (6.06%). Which is the better fit depends on your goals — on Pluang, investors hold OUTFRONT Media Inc. Common Stock for 0 Days and Pfizer Inc for 158 Days on average.
| OUT | PFE | |
|---|---|---|
Market Cap | $5.33B | $161.70B |
Volume | 1,197,618 | 26,828,084 |
Sector | Real Estate | Health |
52-Week High | $33.90 | $29.21 |
52-Week Low | $17.08 | $23.67 |
Typical Hold Time | 0 Days | 158 Days |
Enterprise Value | $9.43B | $213.20B |
Dividend Yield | 4.06% | 6.06% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $28.40, up 0.42% with a bullish technical signal from moving averages. The company maintains strong profitability with a 73.18% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights Pfizer's focus on AI drug discovery and a catalyst-rich pipeline in obesity and oncology for 2026, while analysts maintain a mixed consensus with 40% buy ratings.
Pfizer presents a balanced opportunity with stable cash flows and dividend payments, but faces headwinds from patent cliffs and declining net income margins. The stock trades near analyst consensus targets with moderate upside potential, though execution risks in pipeline development and competitive pressures warrant caution for growth-oriented investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
OUTFRONT Media Inc. is a US out-of-home media REIT that provides advertising space on billboard and transit displays across major markets in US and Canada.
Read more on OUT →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →